Definitive Analysis
Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial

Chaoju Eye Care Holdings Limited

Intrinsic Value Analysis (Discounted Cash Flow)Industry: Medical - Care FacilitiesSector: Healthcare

Fair Value Summary

Current Price$2.65
5Y Range10.66 – 23.74
5Y Selected17.20
(-) Safety Margin35.84%
5Y Buy Price$11.48
Upside (to Buy Price)333.30%
10Y Range12.01 – 26.03
10Y Selected19.02
(-) Safety Margin35.84%
10Y Buy Price$12.70
Upside (to Buy Price)379.17%

Company Predictability & Safety

MetricValue
Revenue R2 (5Y)0.9034
Revenue R2 (10Y)0.9352
Net Income R2 (5Y)0.7126
Net Income R2 (10Y)0.8921
EBITDA R2 (5Y)0.4885
EBITDA R2 (10Y)0.7679
FCF R2 (5Y)0.6104
FCF R2 (10Y)0.8238
Safety Score0.6676

DA 10-Year Projection

Metric2025202620272028202920302031203220332034
% Growth13.28%12.25%11.22%10.19%9.16%8.12%7.09%6.06%5.03%4.00%
Revenue1,592.091,787.091,987.552,190.002,390.492,584.702,768.032,935.833,083.533,206.88
EBITDA460.38516.76574.73633.27691.25747.41800.42848.94891.65927.32
D&A-155.81-174.90-194.52-214.33-233.95-252.96-270.90-287.32-301.78-313.85
EBIT304.56341.87380.21418.94457.30494.45529.52561.62589.87613.47
Pro forma Taxes-79.22-88.92-98.90-108.97-118.95-128.61-137.73-146.08-153.43-159.57
NOPAT225.34252.94281.31309.97338.35365.84391.78415.53436.44453.90
Capital Expenditures-121.05-135.88-151.12-166.51-181.76-196.52-210.46-223.22-234.45-243.83
NWC Investment11.7412.2712.6112.7412.6212.2211.5410.569.297.76
(+) D&A155.81174.90194.52214.33233.95252.96270.90287.32301.78313.85
Free Cash Flow271.85304.23337.33370.53403.16434.49463.76490.20513.06531.68
Diluted Shares Outstanding691,749,500.00691,749,500.00691,749,500.00691,749,500.00691,749,500.00691,749,500.00691,749,500.00691,749,500.00691,749,500.00691,749,500.00

Discounting Periods

MetricDec-25Dec-26Dec-27Dec-28Dec-29Dec-30Dec-31Dec-32Dec-33Dec-34
Period Start6/30/251/1/261/1/271/1/281/1/291/1/301/1/311/1/321/1/331/1/34
Period End12/31/2512/31/2612/31/2712/31/2812/31/2912/31/3012/31/3112/31/3212/31/3312/31/34
Mid-Point9/30/257/2/267/2/277/1/287/2/297/2/307/2/317/1/327/2/337/2/34
Time (t)0.100.451.452.463.464.465.466.467.468.46
Valuation Date1/17/26

Base Case Projected Flows

WACC: 6.83%Terminal Growth: 3.08%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.970.910.850.800.740.700.650.610.57
PV UFCF270.06295.32306.51314.94320.77323.59323.31319.89313.40304.01
Raw: 11,093.90
8,539.81
Raw: 14,630.45
8,093.60

Base Case Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value10,047.4111,185.39
(-) Net Debt-38.00-38.00
Equity Value10,085.4011,223.39
(/) Shares Out691.75691.75
Fair Value$14.58$16.22
(-) Safety Margin35.84%35.84%
Buy Price$9.35$10.41
Current Price$2.65$2.65
Upside (to Buy Price)252.99%292.82%

Conservative Projected Flows

WACC: 7.83%Terminal Growth: 2.58%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.970.900.830.770.710.660.610.570.53
PV UFCF269.81294.09302.40307.80310.59310.42307.27301.20292.36280.96
Raw: 7,883.47
5,848.68
Raw: 10,396.59
5,290.78

Conservative Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value7,333.378,267.68
(-) Net Debt-38.00-38.00
Equity Value7,371.368,305.68
(/) Shares Out691.75691.75
Fair Value$10.66$12.01
(-) Safety Margin35.84%35.84%
Buy Price$6.84$7.70
Current Price$2.65$2.65
Upside (to Buy Price)158.00%190.70%

Aggressive Projected Flows

WACC: 5.83%Terminal Growth: 3.58%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.970.920.870.820.780.730.690.660.62
PV UFCF270.31296.57310.72322.31331.38337.45340.34339.92336.18329.18
Raw: 18,592.19
14,854.87
Raw: 24,519.07
14,756.54

Aggressive Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value16,386.1617,970.91
(-) Net Debt-38.00-38.00
Equity Value16,424.1618,008.91
(/) Shares Out691.75691.75
Fair Value$23.74$26.03
(-) Safety Margin35.84%35.84%
Buy Price$15.23$16.70
Current Price$2.65$2.65
Upside (to Buy Price)474.85%530.31%

Reverse DCF: Market Implied Growth

Current Price$2.65
WACC Used6.8%
IMPLIED REVENUE GROWTH86.63%
Metric2027202820292030203120322033203420352036
Implied Revenue5,189.399,685.1418,075.6933,735.2562,961.22117,506.60219,306.44409,298.85763,887.961,425,669.31
Constant Implied Growth86.63%86.63%86.63%86.63%86.63%86.63%86.63%86.63%86.63%86.63%
Implied Free Cash Flow0.520.971.813.376.3011.7521.9340.9376.39142.57
Discount Factor0.950.850.800.740.700.650.610.570.540.50
Present Value of Implied FCF0.500.821.442.514.397.6713.4023.4040.8971.43

Rolling Historical DCF (Backtest)

Valuation based on actual realized growth.
YearValuation DateActual PriceRealized Growth (5Y)Calculated Fair ValueValuation Delta
20192019-12-31$12.6013.24%$4.49-64.35%
20182018-12-31$12.3714.70%$-0.58-104.70%

Monte Carlo Simulation (1,000 Iterations)

Mean Fair Value
$18.75
Median
$16.24
10th Percentile
$12.09
90th Percentile
$25.84

Fair Value Distribution

$7.91 - $29.47
944
$29.47 - $51.03
49
$51.03 - $72.59
3
$72.59 - $94.15
1
$94.15 - $115.71
1
$115.71 - $137.27
0
$137.27 - $158.83
0
$158.83 - $180.39
0
$180.39 - $201.95
0
$201.95 - $223.50
0
$223.50 - $245.06
0
$245.06 - $266.62
0
$266.62 - $288.18
0
$288.18 - $309.74
1
$309.74 - $331.30
0
$331.30 - $352.86
0
$352.86 - $374.42
0
$374.42 - $395.98
0
$395.98 - $417.54
0
$417.54 - $439.10
0